Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Amann, G"" wg kryterium: Autor


Tytuł :
Pulmonary metastasectomy for soft tissue sarcoma - Report from a dual institution experience at the Medical University of Vienna.
Autorzy :
Schur, S. (AUTHOR)
Hoetzenecker, K. (AUTHOR)
Lamm, W. (AUTHOR)
Koestler, W. J. (AUTHOR)
Lang, G. (AUTHOR)
Amann, G. (AUTHOR)
Funovics, P. (AUTHOR)
Nemecek, E. (AUTHOR)
Noebauer, I. (AUTHOR)
Windhager, R. (AUTHOR)
Klepetko, W. (AUTHOR)
Brodowicz, T. (AUTHOR)
Pokaż więcej
Źródło :
European Journal of Cancer. Nov2007, Vol. 43 Issue 16, p2289-2297. 9p.
URL :
97346914
Czasopismo naukowe
Tytuł :
Clear cell sarcoma of the kidney in Austrian children: Long-term survival after relapse.
Autorzy :
Friesenbichler W; Department of Paediatric Haematology and Oncology, St. Anna Children's Hospital, Medical University, Vienna, Austria.
Lüftinger R; Department of Paediatric Haematology and Oncology, St. Anna Children's Hospital, Medical University, Vienna, Austria.
Kropshofer G; Department of Paediatrics, University Hospital Innsbruck, Innsbruck, Austria.
Henkel M; Department of Paediatrics, Hospital of Barmherzige Schwestern Linz, Linz, Austria.
Amann G; Institute of Pathology, Medical University of Vienna, Vienna, Austria.
Furtwängler R; Department of Paediatrics, University Hospital Homburg/Saar, Homburg, Germany.
Graf N; Department of Paediatrics, University Hospital Homburg/Saar, Homburg, Germany.
Kager L; Department of Paediatric Haematology and Oncology, St. Anna Children's Hospital, Medical University, Vienna, Austria.; Children's Cancer Research Institute, Vienna, Austria.
Pokaż więcej
Źródło :
Pediatric blood & cancer [Pediatr Blood Cancer] 2021 May; Vol. 68 (5), pp. e28860. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients.
Autorzy :
Starzer AM; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Berghoff AS; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Hamacher R; Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.
Tomasich E; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Feldmann K; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Hatziioannou T; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Traint S; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Lamm W; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Noebauer-Huhmann IM; Department of Biomedical Imaging and Image-guided Therapy, Division of General and Paediatric Radiology, Medical University of Vienna, Vienna, Austria.
Furtner J; Department of Biomedical Imaging and Image-guided Therapy, Division of General and Paediatric Radiology, Medical University of Vienna, Vienna, Austria.
Müllauer L; Department of Pathology, Medical University of Vienna, Vienna, Austria.
Amann G; Department of Pathology, Medical University of Vienna, Vienna, Austria.
Bauer S; Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.
Schildhaus HU; Institute of Pathology, University Hospital Essen, Essen, Germany.
Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Heller G; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria .
Brodowicz T; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Mar; Vol. 9 (3).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94.
Autorzy :
Fiedler S; St. Anna Children's Hospital, 1090 Vienna, Austria.; CCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Ambros IM; CCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Glogova E; CCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Benesch M; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical University of Graz, 8036 Graz, Austria.
Urban C; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical University of Graz, 8036 Graz, Austria.
Mayer M; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical University of Graz, 8036 Graz, Austria.
Ebetsberger-Dachs G; Med Campus IV, University Clinic for Pediatrics, Kepler University Hospital, 4020 Linz, Austria.
Bardi E; St. Anna Children's Hospital, 1090 Vienna, Austria.; Med Campus IV, University Clinic for Pediatrics, Kepler University Hospital, 4020 Linz, Austria.
Jones N; Department of Pediatrics, Paracelsus Medical University, 5020 Salzburg, Austria.
Gamper A; Department of Pediatrics, Paracelsus Medical University, 5020 Salzburg, Austria.
Meister B; Department of Pediatric Hematology, Oncology, and Stem-Cell Transplantation, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Crazzolara R; Department of Pediatric Hematology, Oncology, and Stem-Cell Transplantation, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Amann G; Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
Dieckmann K; Department of Radiotherapy, Medical University of Vienna, 1090 Vienna, Austria.
Horcher E; Department of Pediatric Surgery, Medical University of Vienna, 1090 Vienna, Austria.
Kerbl R; Department of Pediatric Medicine, Landeskrankenhaus Leoben, 8700 Leoben, Austria.
Brunner-Herglotz B; CCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Ziegler A; CCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Ambros PF; CCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.
Ladenstein R; St. Anna Children's Hospital, 1090 Vienna, Austria.; CCRI, Children's Cancer Research Institute, 1090 Vienna, Austria.; Department of Pediatric Medicine, Medical University of Vienna, 1090 Vienna, Austria.
Pokaż więcej
Źródło :
Cancers [Cancers (Basel)] 2021 Feb 02; Vol. 13 (3). Date of Electronic Publication: 2021 Feb 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Undifferentiated round cell sarcomas with CIC-DUX4 gene fusion: expanding the clinical spectrum.
Autorzy :
Brčić I; Institute of Pathology, Medical University of Graz, Graz, Austria.
Brodowicz T; Clinical Division of Oncology, Department of Medicine I, Comprehensive Cancer Centre, Medical University Vienna, Vienna, Austria.
Cerroni L; Department of Dermatology, Medical University of Graz, Graz, Austria.
Kashofer K; Institute of Pathology, Medical University of Graz, Graz, Austria.
Serbanescu GL; Department of Oncology, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
Kasseroler MT; Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.
Amann G; Clinical Institute of Pathology, Medical University Vienna, Vienna, Austria.
Scheipl S; Department of Orthopedics and Trauma, Medical University of Graz, Graz, Austria.
Szkandera J; Clinical Division of Medical Oncology, Department of Medicine, Comprehensive Cancer Centre Graz, Medical University of Graz, Graz, Austria.
Leithner A; Department of Orthopedics and Trauma, Medical University of Graz, Graz, Austria.
Liegl-Atzwanger B; Institute of Pathology, Medical University of Graz, Graz, Austria. Electronic address: .
Pokaż więcej
Źródło :
Pathology [Pathology] 2020 Feb; Vol. 52 (2), pp. 236-242. Date of Electronic Publication: 2019 Dec 20.
Typ publikacji :
Journal Article
MeSH Terms :
Oncogene Proteins, Fusion/*genetics
Sarcoma/*genetics
Sarcoma/*pathology
Adult ; Bone Neoplasms/genetics ; Bone Neoplasms/pathology ; Female ; Humans ; Male ; Middle Aged ; Soft Tissue Neoplasms/genetics ; Soft Tissue Neoplasms/pathology ; Young Adult
Czasopismo naukowe
Tytuł :
An optimized, robust and reproducible protocol to generate well-differentiated primary nasal epithelial models from extremely premature infants.
Autorzy :
Martens A; Division of Neonatology, Pediatric Intensive Care & Neuropediatrics, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
Amann G; Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria.
Schmidt K; Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.
Gaupmann R; Division of Pediatric Pulmonology, Allergology and Endocrinology, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
Böhm B; Division of Pediatric Pulmonology, Allergology and Endocrinology, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
Dehlink E; Division of Pediatric Pulmonology, Allergology and Endocrinology, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
Szépfalusi Z; Division of Pediatric Pulmonology, Allergology and Endocrinology, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
Förster-Waldl E; Division of Neonatology, Pediatric Intensive Care & Neuropediatrics, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.; Center for Congenital Immunodeficiencies, Medical University of Vienna, Vienna, Austria.
Berger A; Division of Neonatology, Pediatric Intensive Care & Neuropediatrics, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.
Fyhrquist N; Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Alenius H; Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Wisgrill L; Division of Neonatology, Pediatric Intensive Care & Neuropediatrics, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2019 Dec 27; Vol. 9 (1), pp. 20069. Date of Electronic Publication: 2019 Dec 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Differentiation*
Models, Biological*
Nasal Mucosa/*cytology
Adult ; Case-Control Studies ; Cells, Cultured ; Disease Susceptibility ; Humans ; Infant, Extremely Premature ; Infant, Newborn ; Reproducibility of Results ; Respiratory Tract Diseases/etiology ; Respiratory Tract Diseases/immunology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies